I never thought it had a chance to come back to this price since I missed out on adding when it dropped to 3.50 after the rise to $6+. It was stuck around $4 for quite a while. Now I am adding at these levels.
IMO, the stock is a better buy now than it was below $2. Now we the Elsevier conference in a few weeks and Rudy Tanzi speaking very confidently about PBT2 with the trial results just around the corner. What is not to like? Let them manipulate it down for as long as they can but I will take advantage.
Sentiment: Strong Buy
no way in hell do I buy more until I see data, esoteric, I really hope you are only investing what you are prepared to lose...I have a considerable sum invested awaiting the AD data...but I am also willing to accept a complete loss...just keep that mindset, diversify in other biotechs, and you will be fine...
The Elsevier conference is bigger than most may believe. Pran will be exposed to so many that didn't know about them and once these people get back they will tell everyone else. Word of mouth, the best advertising ever.